Skip to main navigation menu Skip to main content Skip to site footer

Asymmetric sensorineural hearing loss in the diagnosis of vestibular schwannoma

Hipoacusia sensorineural asimétrica en el diagnóstico de schwannoma vestibular



Open | Download


Section
Reflection article

How to Cite
1.
Asymmetric sensorineural hearing loss in the diagnosis of vestibular schwannoma. Rev. Investig. Innov. Cienc. Salud [Internet]. 2022 Feb. 5 [cited 2024 Nov. 23];4(1):109-24. Available from: https://riics.info/index.php/RCMC/article/view/61

Dimensions
PlumX
Erika Celis-Aguilar

    Background:  It is described that 2% of patients with asymmetric hearing loss have retrocochlear lesions. The scrutiny behavior has been based on audiometry. There are several definitions of audiometric asymmetry described in the literature, but without reaching a consensus. Although the gold standard for the diagnosis of vestibular schwannoma is gadolinium magnetic resonance imaging, the clinical suspicion is based on audiometric asymmetry.

    Objective: we review the results published in this regard in the literature and comment on our own experience.

    Reflection: we want to emphasize the importance of studying asymmetric hearing loss patients in order to rule out retrocochlear etiology.

    Conclusions: although there is no clear consensus on the definition of asymmetric hearing loss, the clinical suspicion of a vestibular schwannoma is based on the audiometry.


    Article visits 821 | PDF visits 450


    1. Welling DB., Glasscock ME, Woods CI., Jackson CG. Acoustic neuroma: a cost effective approach. Otolaryngol Head Neck Surg. 1990; 103:364-70. doi: https://doi.org/10.1177/019459989010300305
    2. Bhargava EK, Coyle P, Wong B, Masood A, Qayyum A. To scan or not to scan – a cross-sectional analysis of the clinical efficacy and cost-effectiveness of audiometric protocols for magnetic resonance imaging screening of vestibular schwannomas. Otol & Neurotol. 2019;40(5S):S59-66. doi: https://doi.org/10.1097/MAO.0000000000002215
    3. Murphy M, Selesnick S. Cost effective diagnosis of acoustic neuroma: a philosophical, macroeconomic and technological decision. Otolaryngol Head Neck Surg. 2002; 127:253-9. doi:_https://doi.org/10.1067/mhn.2002.128071
    4. Novak MA. Hearing loss in Neurotologic Diagnosis. En: Jackler R, Brackmann D, editors. Neurotology. Maryland Heights: Mosby; 1994. p. 131-144.
    5. Selesnick SH, Jackler RK, Pitts LW. The changing clinical presentation of acoustic tumors in the MRI era. Laryngoscope. 1993;103:431-436. doi: https://doi.org/10.1002/lary.5541030412
    6. Urben S., Benninger M., Gibbens N. Asymmetric sensorineural hearing loss in a community based population. Otolaryngol Head Neck Surg. 1999; 120:808-14. doi: https://doi.org/10.1026/S0194-5998(99)70318-9
    7. Kanzaki J, Ogawa K, Ogawa S, Yamamoto M, Ikeda S, O-uchi T. Audiologic findings in acoustic neuroma. Acta Otolaryngol Suppl. 1991;487:125-32. doi: https://doi.org/10.3109/00016489109130457
    8. Stangerup S, Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol. 2006;37:547-552. doi: https://doi.org/10.1097/01.mao.0000217356.73463.e
    9. Nikolopuolos T, Fortum H, O’Donoghue G, Baguley D. Acoustic Neuroma Growth: a systematic review of the evidence. Otol Neurotol. 2010;31:478-485. doi: https://doi.org/10.1097/MAO.0b013e3181d279a3.
    10. Lusting LR, Rifkin S, Jackler R, Pitts LW. Acoustic neuromas presenting with normal or symmetrical hearing: Factors associated with diagnosis and outcome. Am J Otology. 1998;19:212-218. PMID:9520059
    11. Hentschel M, Scholte M, Steens S, Kunst H, Rovers M. The diagnostic accuracy of non‐imaging screening protocols for vestibular schwannoma in patients with asymmetrical hearing loss and/or unilateral audiovestibular dysfunction: a diagnostic review and meta‐analysis. Clin Otolaryngol. 2017;42(4):815-23. doi: https://doi.org/10.1111/coa.12788
    12. Nouraei SA, Huys QJ, Chatrath P, Powles J, Harcourt JP. Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifier. Clin Otolaryngol. 2007; 32(4):248-54. doi: https://doi.org/10.1111/j.1365-2273.2007.01460.x
    13. Cheng TC, Wareing MJ. Three-year ear, nose, and throat cross-sectional analysis of audiometric protocols for magnetic resonance imaging screening of acoustic tumors. Otolaryngol Head Neck Surg. 2012;146(3):438-47. doi: https://doi.org/10.1177/0194599811427384
    14. Sheppard IJ, Milford CAM, Anslow P. MRI in the detection of acoustic neuromas: a suggested protocol for screening. Clin Otolaryngol. 1996;21:301-304. doi: https://doi.org/10.1111/j.1365-2273.1996.tb01074.x
    15. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg. 1995;113:179-180. doi: https://doi.org/10.1016/S0194-5998(95)70101-X
    16. Magham CA. Hearing threshold difference between ears and risk of acoustic tumor. Otolaryngol Head Neck Surg. 1991;105:814-7. doi: https://doi.org/10.1177/019459989110500607
    17. Margolis RH., Saly GL. Asymmetric hearing loss: definition, validation and prevalence. Otol Neurootol. 2008;29:422-31. doi: https://doi.org/10.1097/MAO.0b013e31816c7c09
    18. Saliba I, Martineau G, Chagnon M. Asymmetric hearing loss: rule 3000 for screening vestibular asymmetric sensorineural hearing loss. Laryngoscope. 2004;114:1686-1692. doi: https://doi.org/10.1097/MAO.0b013e3181a5297a
    19. Lassaletta L, Calvino M, Morales-Puebla JM, Lapunzina P, la Rosa Rodriguez-de L., Varela-Nieto I, et al. Biomarkers in Vestibular Schwannoma–Associated Hearing Loss. Front Neurol. 2019;10. doi: https://doi.org/10.3389/fneur.2019.00978
    20. Schlauch RS, Levine S. Evaluating hearing threshold differences between ears as a screen for acoustic neuroma. J Speech Hear Res. 1995; 38:1168-1175. doi: https://doi.org/10.1044/jshr.3805.1168
    21. Cueva RA. Auditory brainstem response versus magnetic resonance imaging for the evaluation of asymmetric sensorineural hearing loss. Laryngoscope. 2004;114:1686-1692. doi: https://doi.org/10.1097/00005537-200410000-00003
    22. Lehnhardt E. Neuro-axonal recruitment: a result of selective compression. J Laryngol Otol. 1990;104:185-190. doi: https://doi.org/10.1017/s002221510011223x.
    23. Lonsburry-Martin BL, McCoy M. Otoacoustic emissions: future directions for research and clinical applications. The Hearing Journal. 1992;45:47-52. doi: https.//di.org/10.1044/jshr.3405.964
    24. Cane MA, Lutman ME. Transiently evoked otoacoustic emissions in patients with cerebellopontine angle tumors. Am J Otology. 1994;15:207-216. PMID: 8172303
    25. Norman M; Thornton A. Otoacoustic emissions recorded at high rates in patients with confirmed acoustic neuromas. Am J Otol. 1996;17:736-772. PMID: 3202131
    26. Telishi FF, Stanger B, Widick MP, Balkany TJ, Lonsbury-Martin BL. Distortion-product otoacoustic emission monitoring of cochlear blood flow. Laryngoscope. 1998;108(6):837-842. doi: https://doi.org/10.1097/00005537-199806000-00011
    27. Kagoya R, Shinogami M, Kohno M, Yamasoba T. Distortion-product otoacoustic emission test evaluate cochlear function and differentiate cochlear and vestibular schwannoma. Otolaryngol Head Neck Surg. 2013 Feb;148(29):26771. doi: https://doi.org/10.1177/0194599812469502.
    28. Telian S, Kileny P, Niparko J. Normal auditory brainstem response in patients with acoustic neuroma. Laryngoscope. 1989;99:10-14. doi: https://doi.org/10.1288/00005537-198901000-00003.
    29. Wilson D, Hodgson R, Gustafson M. The sensitivity of auditory brainstem response testing in small acoustic neuromas. Laryngoscope. 1992;102:961-964. doi: https://doi.org/10.1288/00005537-199209000-00001.
    30. Zappia J, O’Connor CA. Rethinking the use of auditory brainstem response in acoustic neuroma screening. Laryngoscope. 1997;107:1388-1392. doi: https://doi.org/10.1097/00005537-199710000-00018.
    31. Toledo H, Pane C. Potenciales evocados auditivos de tallo cerebral. En: PAC Otorrino-1, SMORL y CCC. México: Intersistemas; 1999. p. 11-19.
    32. Bauch CD, Olsen WO, Pool A. ABR indices: sensitivity, specificity, and tumor size. Am J Audiol. 1996;5:97-104. doi: https://doi.org/10.1044/1059-0889.0501.97
    33. Selters W, Brackmann D. Acoustic tumor detection with brainstem electric response audiometry. Arch Otolaryngol. 1977;103:181-187. doi: https://doi.org/10.1001/archotol.1977.00780210037001.
    34. Don M. Auditory brainstem response testing in acoustic neuroma diagnosis. Curr Opin Otolaryngol Head Neck Sur. 2002;10:376-381. doi: https.//doi.org/10.1097/0002084-200210000-00009
    35. Don M, Kwong B, Tanaka C, Brackmann D. The stacked ABR: a sensitive and specific screening tool for detecting small acoustic tumors. Audiol Neurotol. 2005;10:274-290. doi: https://doi.org/10.1159/000086001.
    36. Elberling C, Don M, Kristensen A. Auditory brainstem responses to chirps delivered by an insert earphone with equalized frequency response. J Acoust Soc Am. 2012 Aug;132(2):EL149-54. doi: https://doi.org/10.1121/1.4737915.
    37. Kochanek K, Sliwa L, Gotebiowski M, Pitka A, Skarzynski H. Comparison of 3 ABR methods for diagnosis of retrocochlear hearing impairment. Med Sci Monit. 2015;21:3814-3824. doi: https/doi.org/10.12659/MSM.895291
    38. Gimsing S. Vestibular schwannomas: when to look for it? J Laryngol Otol. 2010;124:258-264. doi: https://doi.org/10.1017/S0022215109991423
    39. Obholzer RJ, Rea PA, Harcourt JP. Magnetic resonance imaging screening for vestibular schwannoma: analysis of published protocols. J Laryngol Otol. 2004;118:329-339. doi: https://doi.org/10.1258/002221504323086480
    40. Celis-Aguilar E, Obeso-Pereda A, Castro-Bórquez A, Coutinho de Toledo H, Vega-Alarcón A, Nuñez-Millán B. Multiple audiometric analysis in the screening of vestibular schwannoma [poster]. In: American Neurotology Society; 2021. doi: https://doi.org/10.6084/m9.figshare.14813100.v1
    Sistema OJS 3.4.0.7 - Metabiblioteca |